Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Oragenics Inc (NY: OGEN )

3.060 +0.090 (+3.03%)
Official Closing Price Updated: 8:00 PM EDT, Oct 2, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 108,515
Open 3.210
Bid (Size) 3.000 (5)
Ask (Size) 3.490 (2)
Prev. Close 2.970
Today's Range 2.870 - 3.330
52wk Range 0.1006 - 8.230
Shares Outstanding 2,539,385
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Why AERWINS Technologies Shares Are Trading Higher By Around 90%; Here Are 20 Stocks Moving Premarket
Gainers AERWINS Technologies Inc. (NASDAQ: AWIN) shares rose 90.2% to $0.2297 in pre-market trading. Aerwins Technologies is considering strategic alternatives for non-core operations including, not... 
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga

Performance

YTD
+2524.36%
+2524.36%
1 Month
-2.24%
-2.24%
3 Month
-7.27%
-7.27%
6 Month
-11.05%
-11.05%
1 Year
+1175.53%
+1175.53%

More News

Read More
Oragenics Enters into Agreement with Lantern Bioworks for Replacement-Therapy Assets
From Oragenics, Inc.
Via Business Wire
Oragenics's Return On Capital Employed Insights
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Oragenics, Inc. Announces Private Placement
From Oragenics, Inc.
Via Business Wire
Oragenics Project to Develop a Variant-Agnostic Protein Antigen for Use in its COVID-19 Intranasal Vaccine Receives Funding from CQDM
From Oragenics, Inc.
Via Business Wire
Oragenics to Participate in the World Vaccine Congress Washington
From Oragenics, Inc.
Via Business Wire
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
Oragenics Announces Positive Results in Several Lantibiotics Compounds Against MRSA and VRE
From Oragenics, Inc.
Via Business Wire
Oragenics Appoints Janet Huffman as Chief Financial Officer Strengthening Executive Leadership Team
From Oragenics, Inc.
Via Business Wire
Oragenics Looks To Boost Potency Of Its Nasal COVID-19 Vaccine With New Licensing Pact
Via Benzinga
Oragenics Enters into an Exclusive Global License Agreement with Inspirevax to Develop Intranasal Covid Vaccine Candidate
From Oragenics, Inc.
Via Business Wire
Oragenics, Inc. Regains Compliance with NYSE American
From Oragenics, Inc.
Via Business Wire
7 Short-Squeeze Stocks to Buy Before They Soar
Via InvestorPlace
Catalyst Pharmaceuticals, Xylem And Other Big Stocks Moving Lower On Monday
Via Benzinga
Metacrine, Equillium And 3 Stocks To Watch Heading Into Tuesday
Via Benzinga
Oragenics, Inc. Discloses One-for-Sixty Reverse Stock Split
From Oragenics, Inc.
Via Business Wire
Oragenics Highlights Encouraging Toxicology Data From Intranasal COVID Vaccine Candidate
Via Benzinga
Why AMC Entertainment Shares Are Trading Lower By Around 13%? Here Are 59 Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Oragenics Reports Favorable Toxicology Results for its COVID-19 Intranasal Vaccine Candidate
From Oragenics, Inc.
Via Business Wire
Oragenics, Inc. Receives NYSE American Notice
From Oragenics, Inc.
Via Business Wire
Oragenics, Inc. Announces New Chair
From Oragenics, Inc.
Via Business Wire
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.